2025 China Antibody Protection Revenue Opportunities Report
Description
The 2025 China Antibody Protection Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Antibody Protection by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in antibody protection in China are WuXi Biologics, Asymchem, Shanghai Pharma Industrial, and Sino Biological. WuXi Biologics is a global leader offering comprehensive antibody manufacturing solutions including antibody-drug conjugates and next-generation cell lines, with large-scale flexible production capacity. Asymchem provides innovative antibody production throughout all stages, emphasizing cutting-edge antibody engineering. Shanghai Pharma Industrial focuses on custom antibody development and large-scale biologics production, serving primarily Asia-Pacific markets but expanding internationally. Sino Biological specializes in producing high-quality antibodies for research and therapeutic use, with growing influence domestically and abroad.
Additional top biotech companies in China involved in antibody drug development include BeiGene and Junshi Biosciences, both focused on innovative cancer immunotherapy antibodies. CanSino Biologics is recognized for vaccine and antibody research, notably in respiratory infections and COVID-19 vaccines, adding to China’s expanding biological therapeutics landscape. These companies illustrate China’s rapid growth and international ambitions in antibody protection, supported by strong R&D and collaborations for global market penetration. The local market is growing fast, projected to reach over $1.65 billion by 2030 driven by demand for antibody therapeutics and research antibodies.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Antibody Protection by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in antibody protection in China are WuXi Biologics, Asymchem, Shanghai Pharma Industrial, and Sino Biological. WuXi Biologics is a global leader offering comprehensive antibody manufacturing solutions including antibody-drug conjugates and next-generation cell lines, with large-scale flexible production capacity. Asymchem provides innovative antibody production throughout all stages, emphasizing cutting-edge antibody engineering. Shanghai Pharma Industrial focuses on custom antibody development and large-scale biologics production, serving primarily Asia-Pacific markets but expanding internationally. Sino Biological specializes in producing high-quality antibodies for research and therapeutic use, with growing influence domestically and abroad.
Additional top biotech companies in China involved in antibody drug development include BeiGene and Junshi Biosciences, both focused on innovative cancer immunotherapy antibodies. CanSino Biologics is recognized for vaccine and antibody research, notably in respiratory infections and COVID-19 vaccines, adding to China’s expanding biological therapeutics landscape. These companies illustrate China’s rapid growth and international ambitions in antibody protection, supported by strong R&D and collaborations for global market penetration. The local market is growing fast, projected to reach over $1.65 billion by 2030 driven by demand for antibody therapeutics and research antibodies.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
